| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/15/1992 | US5147790 Tissue plasminogen activator, biosynthesis |
| 09/15/1992 | US5147788 Baculovirus vectors and methods of use |
| 09/15/1992 | US5147289 Non-specific immune system enhancement |
| 09/15/1992 | CA2106193A1 Means for in vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | CA1307486C Hybridoma production |
| 09/15/1992 | CA1307484C Method for culturing recombinant cells |
| 09/15/1992 | CA1307479C Diagnostic methods and systems for quantifying apo ai |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/13/1992 | WO1992016646A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/13/1992 | WO1992016562A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105990A1 Maize resistant to aryloxyphenoxyalkanecarboxylic acid herbicides |
| 09/13/1992 | CA2105980A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105477A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/12/1992 | WO1992016612A2 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2105997A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502718A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502591A2 Protein non-adsorptive polyurea-urethane polymer coated devices |
| 09/09/1992 | EP0502553A2 Peptide fragment from human villin and antibody thereto |
| 09/09/1992 | EP0502172A1 Biomaterial based on collagen and its applications. |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502105A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
| 09/09/1992 | EP0502099A1 Chimeric proteins |
| 09/09/1992 | EP0494931A4 Monoclonal antibodies to segments of hiv-1 reverse transcriptase |
| 09/09/1992 | EP0473716A4 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 09/08/1992 | US5145777 Plant cells resistant to herbicidal glutamine synthetase inhibitors |
| 09/08/1992 | US5145774 Fluorescent dyes |
| 09/08/1992 | US5145773 Contact with monoclonal antibodies to form antigen-antibody complex |
| 09/08/1992 | US5145770 Cryopreservation of cultured epithelial sheets |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/08/1992 | CA1307221C Brain-derived growth factor |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/07/1992 | CA2061664A1 Protein non-absorptive polyurea-polyurethane polymer coated devices |
| 09/05/1992 | CA2061862A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/03/1992 | WO1992014831A1 Novel invertase gene(s) and uses thereof |
| 09/03/1992 | WO1992014824A1 Newly characterised oxalate oxidase and uses therefor |
| 09/03/1992 | WO1992014815A1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | CA2106099A1 Cultures of permanent lines of human promyelocyte cells and their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501779A1 Antibodies reactive with human cytosolic phospholipase A2 |
| 09/02/1992 | EP0501650A2 Bacillus thuringiensis genes encoding novel coleopteranactive protein toxins |
| 09/02/1992 | EP0501435A1 A serum-free medium for culturing animal cells |
| 09/02/1992 | EP0501233A1 Hybridomas and monoclonal antibodies that inhibit anti-CD3-stimulated T cell proliferation |
| 09/02/1992 | EP0500799A1 Particle mediated transformation of animal skin tissue cells |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0437488A4 Animal model for human disease |
| 09/02/1992 | CA2061738A1 Antibodies reactive with human cytosolic phospholipase a2 |
| 09/01/1992 | US5143843 Method for production of monoclonal antibodies for cancer diagnosis and therapy |
| 09/01/1992 | US5143842 Media for normal human muscle satellite cells |
| 09/01/1992 | CA1306966C Human monocytes cultured in suspension in serum-free medium |
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins |
| 08/29/1992 | CA2104285A1 Recombinant fiv glycoprotein 160 and p24 gag protein |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/27/1992 | CA2059824A1 Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation |
| 08/26/1992 | EP0499993A2 Method for producing human nerve growth factor-2 |
| 08/26/1992 | EP0499932A1 Cancer cell cluster comprising cancer cells and normal cells and preparation thereof |
| 08/26/1992 | EP0499625A1 Conglutinin fragments, their production and use |
| 08/26/1992 | EP0483219A4 Enhancement of musculature in animals |
| 08/26/1992 | EP0229809B1 Animal cell culture |
| 08/26/1992 | CA2059897A1 Bacillus thuringiensis genes encoding novel coleopteran-active protein toxins |
| 08/25/1992 | US5142028 Can be used for elucidation of sugar chain roles in cell functions |
| 08/25/1992 | US5141865 Monoclonal antibodies which bind thromboxane A2 receptor antagonists and diagnostic methods based thereon |
| 08/25/1992 | US5141864 Monoclonal antibody recognizing alpha 2→3 bonds |
| 08/25/1992 | US5141856 Expression of purified ciliary neurotrophic factor |
| 08/25/1992 | US5141806 Chromatographic packing, activated catalysts |
| 08/25/1992 | CA1306707C Anti-human pulmonary adenocarcinoma specific monoclonal antibody |
| 08/25/1992 | CA1306706C Monoclonal antibodies to human gastrointestinal cancer |
| 08/25/1992 | CA1306678C Active specific immune suppression |
| 08/20/1992 | WO1992014829A1 Viral particles having altered host range |
| 08/20/1992 | WO1992014818A2 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013957A1 Stamen-specific promoters from corn |
| 08/20/1992 | WO1992013956A1 Stamen-specific promoters from rice |
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 08/20/1992 | WO1992013892A1 Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 08/20/1992 | WO1992013891A1 Monoclonal antibody to human t cell receptors with gamma chains |
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | WO1992013867A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing |
| 08/20/1992 | WO1992013550A1 Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 08/20/1992 | WO1992001782A3 Sucrose phosphate synthetase (sps), a preparation method and cdna therefor, and use of the cdna for modifying sps expression in plant cells |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2103676A1 Method and agents for promoting wound healing |
| 08/20/1992 | CA2103550A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
| 08/19/1992 | WO1992014814A1 Cell culture medium and method for preparing such medium |
| 08/19/1992 | EP0499555A1 Recombinant DNA coding for a T-cell receptor chain, process for preparation and antibodies and pharmaceutical compositions comprising the same |
| 08/19/1992 | EP0499176A2 Monoclonal antibodies against human pancreatic islet cells |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0499112A1 Antibodies against an IgE receptor |
| 08/19/1992 | EP0499010A1 A method for measuring the activity of angiotensin converting enzyme in biological samples |
| 08/19/1992 | EP0498992A2 Serum-free culture medium containing lysozyme |
| 08/19/1992 | EP0498871A1 Antimicrobial preservation of plasma |
| 08/19/1992 | EP0498858A1 Nested-cone separator |
| 08/19/1992 | EP0449956A4 Novel lymphokine/cytokine genes |
| 08/19/1992 | EP0314744B1 Monokine dosing |